|Flow Cytometry (Flow)||1:10-1:50|
|Western Blot (WB)||1:1000|
|Tested Species reactivity||Human, Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||KLH conjugated synthetic peptide between 104-132 amino acids from the C-terminal region of human HRASLS3|
|Purification||Ammonium sulfate precipitation, Size-exclusion - Dialysis|
|Contains||0.09% sodium azide|
|Storage conditions||-20° C, Avoid Freeze/Thaw Cycles|
PLA2G16 specifically catalyzes the release of fatty acids from phospholipids in adipose tissue. It also has a weak lysophospholipase activity. Tumor suppressor that may be involved in interferon-dependent cell death.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Adipose-specific phospholipase A2; adipose-specific PLA2; AdPLA; Ca-independent phospholipase A1/2; Group XVI phospholipase A1/A2; Group XVI phospholipase A2; H-rev 107 protein; H-rev 107 protein homolog; H-REV107; H-REV107-1; HRAS like suppressor 3; HRAS-like suppressor 1; HRAS-like suppressor 3; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; LRAT-like protein 3; phospholipase A2, group XVI; Renal carcinoma antigen NY-REN-65
Gene Aliases: AdPLA; C78643; H-rev107; H-REV107-1; HRASLS3; HREV107; HREV107-1; HREV107-3; HRSL3; MLP-3; PLA2G16
If an Invitrogen™ antibody doesn’t perform as described on our website or datasheet, we’ll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.